Title/Author/Domains | Description | Performance | Status | |
---|---|---|---|---|
MS-TAQ Bulgarian
|
The MS-TAQ is a self-administered tool for identifying barriers to adherence for MS patients taking disease-modifying therapies. The tool was originally developed by PatientsLikeMe, using the online platform for refining and validating questions. |
- |
|
|
MS-TAQ English
|
The MS-TAQ is a self-administered tool for identifying barriers to adherence for MS patients taking disease-modifying therapies. The tool was originally developed by PatientsLikeMe, using the online platform for refining and validating questions. |
- |
|
|
MS-TAQ German
|
The MS-TAQ is a self-administered tool for identifying barriers to adherence for MS patients taking disease-modifying therapies. The tool was originally developed by PatientsLikeMe, using the online platform for refining and validating questions. |
- |
|
|
MS-TAQ Greek
|
The MS-TAQ is a self-administered tool for identifying barriers to adherence for MS patients taking disease-modifying therapies. The tool was originally developed by PatientsLikeMe, using the online platform for refining and validating questions. |
- |
|
|
MS-TAQ Italian
|
The MS-TAQ is a self-administered tool for identifying barriers to adherence for MS patients taking disease-modifying therapies. The tool was originally developed by PatientsLikeMe, using the online platform for refining and validating questions. |
- |
|
|
MS-TAQ Polish
|
The MS-TAQ is a self-administered tool for identifying barriers to adherence for MS patients taking disease-modifying therapies. The tool was originally developed by PatientsLikeMe, using the online platform for refining and validating questions. This version is in Polish. |
- |
|
|
MS-TAQ Spanish
|
The MS-TAQ is a self-administered tool for identifying barriers to adherence for MS patients taking disease-modifying therapies. The tool was originally developed by PatientsLikeMe, using the online platform for refining and validating questions. |
- |
|